Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 3 clinical study evaluating ELX-02 for Cystic Fibrosis

X
Trial Profile

Phase 3 clinical study evaluating ELX-02 for Cystic Fibrosis

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 22 Aug 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Exaluren (Primary)
  • Indications Cystic fibrosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Aug 2023 According to a Eloxx Pharmaceuticals media release, company will initiate this trial activities, which is subject to sufficient funding, in the third quarter of 2023 and that maintain compliance with debt covenants, company believe that the current cash position will be sufficient to fund our operations into the fourth quarter of 2023.
    • 22 Nov 2021 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top